Borislav K.
- Country
- Bulgaria
- Department
- Department of Neurological Diseases
Research Overview
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
Data & Insights
Has run more than one trial at 102 of 403 partner sites.
Specializations
Stroke Prevention and Treatment
This investigator specializes in the management of acute ischemic stroke and high-risk transient ischemic attack (TIA), with particular focus on innovative therapeutic approaches for stroke prevention.
- Post-stroke Prevention Strategies
- Non-cardioembolic Ischemic Stroke Management
- Acute Stroke Interventions
The research activities concentrate on evaluating novel therapeutic agents for reducing stroke risk in vulnerable patient populations.
Antithrombotic Research
The investigator focuses on studying advanced antithrombotic therapies, particularly examining new oral anticoagulants in combination with antiplatelet treatments for stroke prevention.
- Novel Oral Anticoagulants
- Antiplatelet Therapy Optimization
- Bleeding Risk Assessment
Their work includes evaluation of FXIa inhibitors and their role in preventing recurrent strokes.
Clinical Outcomes Research
The investigator studies therapeutic efficacy in stroke prevention, with emphasis on measuring clinical outcomes in high-risk patient populations.
- Stroke Risk Reduction
- Safety Profile Assessment
- Treatment Effectiveness Evaluation
Their research encompasses comprehensive evaluation of both therapeutic benefits and safety considerations in stroke prevention strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.